This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Brazilian Network for Studies on Diabetes | |
|---|---|
| Name | Brazilian Network for Studies on Diabetes |
| Native name | Rede Brasileira de Estudos sobre Diabetes |
| Established | 2000s |
| Type | Research network |
| Focus | Diabetes, endocrinology, public health |
| Headquarters | São Paulo, Brazil |
| Key people | Notable investigators across Brazilian institutions |
Brazilian Network for Studies on Diabetes is a national clinical and epidemiological research network focused on diabetes mellitus and related metabolic disorders in Brazil. The Network coordinates multicenter studies, clinical trials, cohort investigations, and translational research across Brazilian research institutions, teaching hospitals, and public health agencies. The initiative connects academic groups, specialist clinics, and policy-oriented bodies to generate evidence on prevention, diagnosis, treatment, and outcomes for people with type 1 diabetes, type 2 diabetes, gestational diabetes, and diabetes complications.
The Network emerged in the early 21st century through initiatives by leading Brazilian universities and hospitals such as Universidade de São Paulo, Universidade Estadual de Campinas, Universidade Federal do Rio de Janeiro, Hospital das Clínicas da Faculdade de Medicina da USP, and Hospital Sírio-Libanês, aligning with agendas from national bodies including Ministry of Health (Brazil), National Council for Scientific and Technological Development, and regional health secretariats in states like São Paulo (state), Rio de Janeiro (state), and Bahia (state). Early impetus drew on collaborations with international research entities such as World Health Organization, Pan American Health Organization, International Diabetes Federation, National Institutes of Health, and the Wellcome Trust. Founders included clinician-researchers affiliated with institutions like Fundação Oswaldo Cruz, Universidade Federal de São Paulo, and specialty societies including the Brazilian Diabetes Society. Over subsequent years the Network expanded through ties with provincial medical schools such as Universidade Federal de Minas Gerais and Universidade Federal do Rio Grande do Sul, and by engaging centers in Amazonian and Northeastern regions to address geographic disparities.
Governance typically comprises a steering committee, scientific advisory board, and working groups representing participating institutions such as Instituto do Coração, Instituto Dante Pazzanese de Cardiologia, and university hospitals in Brasília and Salvador. Institutional partners include academic departments of endocrinology and departments of internal medicine at institutions like Universidade Federal de Pernambuco and Universidade Federal de Santa Catarina. The Network follows ethical oversight from research ethics committees linked to hospitals like Hospital de Clínicas de Porto Alegre and national regulations from agencies such as Brazilian National Health Surveillance Agency. Leadership roles often rotate among principal investigators affiliated with centers including Universidade Estadual Paulista, Instituto de Medicina Tropical de São Paulo, and specialty institutes in Brasília. Working groups address protocol standardization, data management, biobanking, and community engagement with ties to societies like Associação Médica Brasileira.
Programs encompass population-level epidemiology, genetics, biomarker discovery, health services research, and implementation science involving partners such as Fiocruz, Fundação de Amparo à Pesquisa do Estado de São Paulo, and regional research foundations. Projects have ranged from genetic association studies involving Brazilian cohorts at institutions like Laboratório de Genética Humana to glycemic control and comorbidity research led by endocrinology units at Hospital das Clínicas de Ribeirão Preto. Collaborative projects have incorporated methods and standards from international consortia such as Global Burden of Disease, EPIC-Norfolk, and UK Biobank to adapt protocols for Brazilian populations. Specific program areas have included gestational diabetes surveillance with maternity hospitals like Maternidade Escola Assis Chateaubriand and cardiovascular risk interventions coordinated with cardiology centers including Instituto do Coração (InCor).
The Network administers multicenter clinical trials and longitudinal cohorts recruiting from tertiary centers and primary care networks such as municipal health systems in São Paulo (city), Rio de Janeiro (city), and Fortaleza (city). Cohort studies track incidence and complications in diverse populations including urban, rural, and indigenous communities served by institutions like Universidade Federal do Acre and hospitals in the Amazon region. Randomized trials have tested pharmacologic agents, glucose monitoring strategies, and lifestyle interventions in collaboration with academic trial units at Hospital Israelita Albert Einstein and clinical research centers supported by agencies such as Brazilian Agency for Industrial Research and Development. Data harmonization efforts align with protocols from multinational trials like ADVANCE, ACCORD, and DCCT/EDIC to enable pooled analyses.
The Network maintains formal and informal partnerships with international organizations including World Diabetes Foundation, International Society for Pediatric and Adolescent Diabetes, and research universities such as Harvard University and University of Oxford through investigator exchanges and joint publications. Domestic collaborations include state health departments, municipal secretariats, and specialty societies like Sociedade Brasileira de Endocrinologia e Metabologia and professional groups in obstetrics, nephrology, and cardiology. Partnerships extend to pharmaceutical and diagnostics sectors under clinical trial agreements and to non-governmental organizations active in chronic disease advocacy such as Associação Brasileira de Diabetes.
Funding sources mix national research agencies like CNPq, FAPESP, CAPES, and state-level foundations alongside international grants from entities such as Bill & Melinda Gates Foundation and bilateral science programs. Infrastructure resources include biobanks at institutions like Instituto de Pesquisa Pelé Pequeno Príncipe, data centers hosted by university IT departments, and clinical trial units in private hospitals including Hospital Alemão Oswaldo Cruz. In-kind support arises from participating hospitals, municipal health services, and laboratory networks including reference labs in São Paulo and Rio Grande do Sul.
Outputs include peer-reviewed publications, national guidelines informally influencing recommendations from Ministry of Health (Brazil) and specialty societies, and capacity building for clinical research across tertiary and regional centers. The Network’s data have aided surveillance efforts aligned with Sistema Único de Saúde priorities, informed screening programs in maternity and primary care networks, and contributed evidence used in health technology assessments at agencies such as CONITEC. Training initiatives have expanded clinical trial literacy at medical schools like Universidade Federal de Goiás and strengthened translational links among endocrinology, cardiology, nephrology, and obstetrics services.
Category:Medical research networks